ロード中...
Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
BACKGROUND: India has the world’s highest tuberculosis burden, and Mumbai is particularly affected by multidrug resistant tuberculosis (MDR-TB). WHO recommends short, intensive treatment (“Short Course”) for previously untreated pulmonary MDR-TB patients but does not require universal drug susceptib...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350313/ https://ncbi.nlm.nih.gov/pubmed/30691407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-3726-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|